Annual Shareholders Equity
$741.04 M
-$64.70 M-8.03%
31 December 2023
Summary:
10x Genomics annual stockholders equity is currently $741.04 million, with the most recent change of -$64.70 million (-8.03%) on 31 December 2023. During the last 3 years, it has fallen by -$76.53 million (-9.36%). TXG annual shareholders equity is now -9.36% below its all-time high of $817.57 million, reached on 31 December 2021.TXG Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$722.80 M
-$1.25 M-0.17%
30 September 2024
Summary:
10x Genomics quarterly stockholders equity is currently $722.80 million, with the most recent change of -$1.25 million (-0.17%) on 30 September 2024. Over the past year, it has dropped by -$18.24 million (-2.46%). TXG quarterly shareholders equity is now -85.86% below its all-time high of $5.11 billion, reached on 01 December 2014.TXG Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXG Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -2.5% |
| 3 y3 years | -9.4% | -11.6% |
| 5 y5 years | +76.4% | +72.1% |
TXG Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -9.4% | at low | -11.6% | +0.6% |
| 5 y | 5 years | -9.4% | +76.4% | -12.4% | +84.7% |
| alltime | all time | -9.4% | +436.9% | -85.9% | +428.6% |
10x Genomics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $722.80 M(-0.2%) |
| June 2024 | - | $724.06 M(+0.7%) |
| Mar 2024 | - | $718.83 M(-3.0%) |
| Dec 2023 | $741.04 M(-8.0%) | $741.04 M(-0.6%) |
| Sept 2023 | - | $745.22 M(-6.1%) |
| June 2023 | - | $793.30 M(-1.1%) |
| Mar 2023 | - | $802.38 M(-0.4%) |
| Dec 2022 | $805.74 M(-1.4%) | $805.74 M(+3.9%) |
| Sept 2022 | - | $775.79 M(-1.0%) |
| June 2022 | - | $783.52 M(-2.9%) |
| Mar 2022 | - | $806.68 M(-1.3%) |
| Dec 2021 | $817.57 M(+10.6%) | $817.57 M(+2.2%) |
| Sept 2021 | - | $800.22 M(+2.0%) |
| June 2021 | - | $784.59 M(+4.3%) |
| Mar 2021 | - | $752.46 M(+1.8%) |
| Dec 2020 | $739.07 M | $739.07 M(-10.4%) |
| Sept 2020 | - | $825.08 M(+110.9%) |
| June 2020 | - | $391.27 M(-4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $409.07 M(-2.6%) |
| Dec 2019 | $420.08 M(-291.0%) | $420.08 M(-0.3%) |
| Sept 2019 | - | $421.45 M(+2655.3%) |
| June 2019 | - | $15.30 M(-107.0%) |
| Dec 2018 | -$219.99 M(+95.5%) | -$219.99 M(-104.5%) |
| Dec 2017 | -$112.51 M | - |
| Sept 2017 | - | $4.87 B(+2.4%) |
| June 2017 | - | $4.76 B(+8.5%) |
| Mar 2017 | - | $4.38 B(+9.8%) |
| Dec 2016 | - | $3.99 B(-6.3%) |
| Sept 2016 | - | $4.26 B(+5.4%) |
| June 2016 | - | $4.05 B(-6.8%) |
| Mar 2016 | - | $4.34 B(+5.5%) |
| Dec 2015 | - | $4.11 B(-17.8%) |
| Sept 2015 | - | $5.01 B(+1.4%) |
| June 2015 | - | $4.94 B(+0.9%) |
| Mar 2015 | - | $4.90 B(-4.2%) |
| Dec 2014 | - | $5.11 B |
FAQ
- What is 10x Genomics annual stockholders equity?
- What is the all time high annual shareholders equity for 10x Genomics?
- What is 10x Genomics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for 10x Genomics?
- What is 10x Genomics quarterly shareholders equity year-on-year change?
What is 10x Genomics annual stockholders equity?
The current annual shareholders equity of TXG is $741.04 M
What is the all time high annual shareholders equity for 10x Genomics?
10x Genomics all-time high annual stockholders equity is $817.57 M
What is 10x Genomics quarterly stockholders equity?
The current quarterly shareholders equity of TXG is $722.80 M
What is the all time high quarterly shareholders equity for 10x Genomics?
10x Genomics all-time high quarterly stockholders equity is $5.11 B
What is 10x Genomics quarterly shareholders equity year-on-year change?
Over the past year, TXG quarterly stockholders equity has changed by -$18.24 M (-2.46%)